Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  504 results for ""MALARIA vaccines""

Your Filters

Subject : antimalarials
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.

  • Authors : Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, West Africa, Burkina Faso. .; Ouattara D

Subjects: Artemisinins*/Artemisinins*/Artemisinins*/therapeutic use ; Artemisinins*/Artemisinins*/Artemisinins*/administration & dosage ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use

  • Source: Malaria journal [Malar J] 2024 Dec 18; Vol. 23 (1), pp. 377. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

Connect Read More Add to Saved list
×
Academic Journal

The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.

Subjects: Artemisinins*/Artemisinins*/Artemisinins*/therapeutic use ; Artemisinins*/Artemisinins*/Artemisinins*/administration & dosage ; Quinolines*/Quinolines*/Quinolines*/administration & dosage

  • Source: The Lancet. Global health [Lancet Glob Health] 2024 Nov; Vol. 12 (11), pp. e1838-e1848.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X

Record details

Read More Add to Saved list
×
Academic Journal

Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain.

  • Authors : Geens R; Laboratory of Medical Biochemistry (LMB), University of Antwerp, Antwerp, Belgium.; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/chemistry ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/metabolism ; Antimalarials*

  • Source: Protein science : a publication of the Protein Society [Protein Sci] 2024 Jan; Vol. 33 (1), pp. e4852.Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

  • Authors : Potter GE; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA. .; Callier V

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Malaria*/Malaria*/Malaria*/drug therapy ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/therapeutic use

  • Source: Malaria journal [Malar J] 2023 Dec 19; Vol. 22 (1), pp. 383. Date of Electronic Publication: 2023 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Plasmodium knowlesi in pig-tailed macaques: a potential new model for malaria vaccine research.

  • Authors : Shears MJ; Department of Laboratory Medicine and Pathology, University of Washington, 750 Republican Street, F870, Seattle, WA, 98109, USA.; Center for Emerging and Re-Emerging Infectious Diseases, University of Washington, 750 Republican Street, Seattle, WA, 98109, USA.

Subjects: Plasmodium knowlesi*/Plasmodium knowlesi*/Plasmodium knowlesi*/genetics ; Malaria Vaccines* ; Antimalarials*

  • Source: Malaria journal [Malar J] 2023 Dec 13; Vol. 22 (1), pp. 379. Date of Electronic Publication: 2023 Dec 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.

Subjects: Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/drug therapy ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/prevention & control ; Antimalarials*

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 May; Vol. 23 (5), pp. 578-588. Date of Electronic Publication: 2023 Jan 25.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Malaria therapeutics: are we close enough?

  • Authors : Tripathi H; Department of Biotechnology, Central University of Rajasthan, NH-8, Bandarsindri, 305817, Rajasthan, India.; Bhalerao P

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/therapeutic use ; Malaria*/Malaria*/Malaria*/diagnosis ; Malaria*/Malaria*/Malaria*/drug therapy

  • Source: Parasites & vectors [Parasit Vectors] 2023 Apr 14; Vol. 16 (1), pp. 130. Date of Electronic Publication: 2023 Apr 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101462774 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-3305

Record details

Read More Add to Saved list
×
Academic Journal

Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial.

  • Authors : van der Boor SC; Department of Medical Microbiology, Radboud Center for Infectious Diseases, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA, Nijmegen, The Netherlands.; Alkema M

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Insect Bites and Stings*/Insect Bites and Stings*/Insect Bites and Stings*/drug therapy ; Malaria*/Malaria*/Malaria*/prevention & control

  • Source: BMC medicine [BMC Med] 2023 Apr 07; Vol. 21 (1), pp. 137. Date of Electronic Publication: 2023 Apr 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope.

  • Authors : Tripathi P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Bender MF

Subjects: Antimalarials* ; Malaria Vaccines* ; Malaria*

  • Source: Structure (London, England : 1993) [Structure] 2023 Apr 06; Vol. 31 (4), pp. 480-491.e4. Date of Electronic Publication: 2023 Mar 16.Publisher: Cell Press Country of Publication: United States NLM ID: 101087697 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana.

  • Authors : Adeshina OO; Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.; Nyame S

Subjects: Malaria Vaccines* ; Malaria*/Malaria*/Malaria*/prevention & control ; Antimalarials*

  • Source: Health policy and planning [Health Policy Plan] 2023 Jan 06; Vol. 38 (1), pp. 28-37.Publisher: Oxford University Press in association with the London School of Hygiene and Tropical Medicine Country of Publication: England NLM ID: 8610614

Record details

Read More Add to Saved list
×
  • 1-10 of  504 results for ""MALARIA vaccines""